REGENERON PHARMACEUTICALS revenue breakdown overview

REGENERON PHARMACEUTICALS revenue for the last year amounted to 11.04 B CHF, the most of which — 11.04 B CHF — came from its highest performing source at the moment, Medicines, the year earlier bringing 11.26 B CHF. The greatest contribution to the revenue figure was made by United States — last year it brought REGENERON PHARMACEUTICALS 5.69 B CHF, and the year before that — 6.31 B CHF.